Fierce Healthcare
APRIL 2, 2023
Cano Health stock hits record low after 3 directors resign amid concerns over CEO's leadership hlandi Sun, 04/02/2023 - 14:58
Pharma Marketing Network
APRIL 2, 2023
The world of digital marketing is rapidly evolving and the rise of privacy concerns is leading to a cookieless future. In recent years, consumers have become increasingly aware of the way their data is being collected and used, and as a result, regulators have introduced new privacy laws and browser providers have started to block third-party cookies.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Physician Pharmacist
APRIL 2, 2023
As we know applying to medical school involves significant planning, adequate coordination, and efficient execution. As a pharmacy student or graduate, this can be even more challenging as we balance our daily education responsibilities with a very unfamiliar application process. 2023 has brought new changes to the allopathic (MD) primary application known as "AMCAS," specifically seen in the Work/Activities Section!
Med Ed 101
APRIL 2, 2023
Polypharmacy is something I’m extremely passionate about. In my work as a consultant pharmacist, there isn’t a much better feeling for me than eliminating medications that the patient doesn’t need. To successfully minimize polypharmacy (check out my 10 commandments), I think it is critical to identify the most important reasons why we don’t reduce medications. […] The post 3 Big Reasons Why We Don’t Reduce Medications appeared first on Med Ed 101.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
PharmaShots
APRIL 2, 2023
Shots: The EMA’s CHMP has issued a positive opinion recommending the approval of Briumvi for adult patients with RMS with active disease defined by clinical or imaging features. The EC’s decision is expected in ~2mos. The opinion was based on the P-III trials (ULTIMATE I & II) evaluating Briumvi vs teriflunomide in 1094 patients across 10 countries.
STAT
APRIL 2, 2023
WALTHAM, Mass. — The coordinator of the Biden administration’s Covid-19 response team called on doctors to take a leadership role with patients to battle medical misinformation and disinformation, linking the continuing death toll in part to such erroneous messaging. Speaking to an audience of physicians at a conference near Boston Friday, Ashish Jha reminded them they are skilled at dealing with uncertainty, just as when they explain to a patient they don’t know whether wha
Expert insights. Personalized for you.
69 
Let's personalize your content